UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Senolytic CAR T cells reverse senescence-associated pathologies

Nature (London), 2020-07, Vol.583 (7814), p.127-132

2020

Volltextzugriff (PDF)

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4111

2021

Volltextzugriff (PDF)

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

Kidney international, 2014-03, Vol.85 (3), p.636-640

2014

Volltextzugriff (PDF)

An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting

Biotechnology and bioengineering, 2024-10, Vol.121 (10), p.3169-3180

2024

Volltextzugriff (PDF)

The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

FEBS letters, 2010-05, Vol.584 (9), p.1923-1930

2010

Volltextzugriff (PDF)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Journal of translational medicine, 2022-03, Vol.20 (1), p.135-135, Article 135

2022

Volltextzugriff (PDF)

Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner

Cell biology international, 2024-11, Vol.48 (11), p.1714-1730

2024

Volltextzugriff (PDF)

uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells

Cellular and molecular life sciences : CMLS, 2021-03, Vol.78 (6), p.3057-3072

2021

Volltextzugriff (PDF)

Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System

The Journal of biological chemistry, 2017-02, Vol.292 (7), p.2741-2753

2017

Volltextzugriff (PDF)

Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein–Protein Interaction

Biochemistry (Easton), 2017-03, Vol.56 (12), p.1768-1784

2017

Volltextzugriff (PDF)

The urokinase receptor interactome

Current pharmaceutical design, 2011-06, Vol.17 (19), p.1874-1889

2011

Volltextzugriff (PDF)

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer

Cancers, 2022-01, Vol.14 (3), p.498

2022

Volltextzugriff (PDF)

oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4

Journal of molecular and cellular cardiology, 2014-01, Vol.66, p.72-82

2014

Volltextzugriff (PDF)

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

Oncogene, 2013-05, Vol.32 (18), p.2282-2291

2013

Volltextzugriff (PDF)

An open label trial of anakinra to prevent respiratory failure in COVID-19

eLife, 2021-03, Vol.10

2021

Volltextzugriff (PDF)

Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer

Clinical cancer research, 2009-07, Vol.15 (14), p.4722-4732

2009

Volltextzugriff (PDF)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

Frontiers in immunology, 2021-12, Vol.12, p.780641-780641

2021

Volltextzugriff (PDF)

Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (7), p.2070-2081

2013

Volltextzugriff (PDF)

Moonlighting glycolytic protein glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH): an evolutionarily conserved plasminogen receptor on mammalian cells

The FASEB journal, 2017-06, Vol.31 (6), p.2638-2648

2017

Volltextzugriff (PDF)

The uPA/uPAR system in astrocytic wound healing

Neural regeneration research, 2022-11, Vol.17 (11), p.2404-2406

Yepes, Manuel

2022

Volltextzugriff (PDF)

Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma

Journal of cellular physiology, 2020-09, Vol.235 (9), p.6268-6286

2020

Volltextzugriff (PDF)

VEGF-initiated angiogenesis and the uPA/uPAR system

Cell adhesion & migration, 2012-11, Vol.6 (6), p.535-540

2012

Volltextzugriff (PDF)

Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma

The oncologist (Dayton, Ohio), 2021-08, Vol.26 (8), p.e1460-e1469

2021

Volltextzugriff (PDF)

uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view

Thrombosis and haemostasis, 2007-03, Vol.97 (3), p.336-342

2007

Volltextzugriff (PDF)

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (3), p.e2212991120-e2212991120

2023

Volltextzugriff (PDF)

1 – 25 von 4.423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.081)
Mit Volltextzugriff
(3.724)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.754)
Life Sciences & Biomedicine
(3.571)
Humans
(3.498)
Receptors, Urokinase Plasminogen Activator
(1.905)
Animals
(1.476)
Female
(1.373)
Urokinase-Type Plasminogen Activator - Metabolism
(1.327)
Biological And Medical Sciences
(1.281)
Receptors, Cell Surface - Metabolism
(1.025)
Male
(1.019)
Medical Sciences
(881)
Oncology
(858)
Mice
(847)
Biochemistry & Molecular Biology
(726)
Receptors, Urokinase Plasminogen Activator - Metabolism
(681)
Middle Aged
(674)
Cell Biology
(651)
Adult
(581)
Urokinase
(569)
Tumors
(565)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.069)
EZB Electronic Journals Library
(2.577)
IngentaConnect
(1.861)
Journals@Ovid
(1.729)
NUS Single-Journal Subscriptions
(1.143)
IngentaConnect Journals
(843)
Elsevier ScienceDirect Journals Complete
(731)
Wiley-Blackwell Journals
(708)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(561)
Wiley Online Library
(555)
2022 ECC(Springer)
(384)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(257)
North East Research Libraries Nature Academic Titles
(171)
Oxford Journals Online Current
(167)
Taylor & Francis Journals
(121)
Oxford Journals 2020 Medicine
(114)
Taylor & Francis
(109)
Thieme_化学药学期刊
(101)
Taylor & Francis Current Content Access
(97)
JSTOR All Journals
(93)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Senolytic CAR T cells reverse senescence-associated pathologies

The Urokinase Receptor: A Multifunctional Receptor in Cancer Cell Biology. Therapeutic Implications

The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis

An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting

The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

Mesenchymal stem/stromal cells alleviate early‐stage pulmonary fibrosis in a uPAR‐dependent manner

uPAR-expressing melanoma exosomes promote angiogenesis by VE-Cadherin, EGFR and uPAR overexpression and rise of ERK1,2 signaling in endothelial cells

Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System

Small Molecules Engage Hot Spots through Cooperative Binding To Inhibit a Tight Protein–Protein Interaction

The urokinase receptor interactome

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer

oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4

CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer

An open label trial of anakinra to prevent respiratory failure in COVID-19

Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

Targeting uPAR with Antagonistic Recombinant Human Antibodies in Aggressive Breast Cancer

Moonlighting glycolytic protein glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH): an evolutionarily conserved plasminogen receptor on mammalian cells

The uPA/uPAR system in astrocytic wound healing

Downregulation of uPAR promotes urokinase translocation into the nucleus and epithelial to mesenchymal transition in neuroblastoma

VEGF-initiated angiogenesis and the uPA/uPAR system

Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma

uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane

Suchergebnisse filtern